Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that it has selected ASC36, a once-monthly, potentially best-in-class subcutaneously administered amylin receptor agonist, as a clinical ...

Rice University has announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary hub that unites ...